Michael A. Metzger - Oct 25, 2021 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
President and COO, Director
Signature
/s/ Michael A. Metzger
Stock symbol
SNDX
Transactions as of
Oct 25, 2021
Transactions value $
-$728,960
Form type
4
Date filed
10/27/2021, 04:11 PM
Previous filing
Sep 28, 2021
Next filing
Dec 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Options Exercise $322K +44.7K +253.15% $7.20 62.4K Oct 25, 2021 Direct
transaction SNDX Common Stock Sale -$855K -44.7K -71.68% $19.13 17.7K Oct 25, 2021 Direct F1, F2
transaction SNDX Common Stock Options Exercise $117K +16.3K +92.28% $7.20 34K Oct 26, 2021 Direct
transaction SNDX Common Stock Sale -$313K -16.3K -47.99% $19.20 17.7K Oct 26, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -44.7K -100% $0.00* 0 Oct 25, 2021 Common Stock 44.7K $7.20 Direct F4
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -16.3K -100% $0.00* 0 Oct 26, 2021 Common Stock 16.3K $7.20 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
F2 The share price ranged from $19.00 to $19.48
F3 The sales price ranged from $19.01 to $19.33
F4 This option is fully vested.